[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Kyungpook National University Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":108},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,38,63,86],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100613379",false,"NCT07265817","Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms","Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms: Randomized Double Blinded Study","Inclusion Criteria:\n\n* Patients who have positive results in PCR or culture of rectal swab.\n\nExclusion Criteria:\n\n* Not provide a consent.","ALL","19 Years",{"count":18,"type":19},60,"ESTIMATED","INTERVENTIONAL",[22],"NA","The aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.",[25],"Carbapenem-Resistant Enterobacteriaceae Colonization","NOT_YET_RECRUITING","2025-11-24",{"date":29,"type":30},"2025-12-05","ACTUAL",{"date":32,"type":19},"2025-12-01",{"date":34,"type":19},"2027-10-01",{"name":36,"class":37},"Kyungpook National University Hospital","OTHER",{"id":39,"slug":4,"hasResults":10,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":4,"eligibilityCriteria":42,"healthyVolunteers":43,"sex":15,"minAge":44,"maxAge":45,"enrollmentInfo":46,"targetDuration":4,"studyType":48,"phases":4,"briefSummary":49,"conditions":50,"keywords":4,"overallStatus":53,"whyStopped":4,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},"100211241","NCT02026843","Analysis of Biomarkers From Patients With Chorioretinal Diseases","Inclusion Criteria:\n\n* age over 20 years\n* patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.\n* patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.\n* control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.\n\nExclusion Criteria:\n\n* under the age of 20 years\n* patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor\n* patients that did not signed the informed consent of the trial\n* patients with intraocular inflammations or infections that requiring any pharmaceutical agent\n* patients with recent ocular trauma",true,"20 Years","80 Years",{"count":47,"type":19},100,"OBSERVATIONAL","This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.",[51,52],"Diabetic Retinopathy","Macular Degeneration","RECRUITING","2025-03-03",{"date":56,"type":30},"2025-03-06",{"date":58,"type":4},"2012-04",{"date":60,"type":19},"2031-04",{"name":36,"class":37},1,{"id":64,"slug":4,"hasResults":10,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":4,"eligibilityCriteria":68,"healthyVolunteers":43,"sex":15,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":4,"studyType":48,"phases":4,"briefSummary":73,"conditions":74,"keywords":4,"overallStatus":53,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":62},"100532610","NCT06215040","The Treatment Effect for Asymptomatic Common Bile Duct Stone","Multicenter Prospective Study for Efficacy of Asymptomatic Common Bile Duct Stone Treatment","Inclusion Criteria:\n\n* diagnosed as common bile duct stone by image modality examination\n* agreement for this study enrollment\n\nExclusion Criteria:\n\n* no definite common bile duct stone by image modality examination\n* symptomatic patients who complain with fever\u002Fabdominal pain that compatible with common bile duct stone related symptom\n* previously diagnosed as pancreatobiliary malignancy\n* previously treated by endoscopic or percutaneous treatment for bile duct stones\n* severe cardio or pulmonary disease\n* pregnancy or possibility of pregnancy\n* who do not agree with study enrollment","18 Years","85 Years",{"count":72,"type":19},120,"This study is prospective, multicenter study for identify the characteristics of asymptomatic common bile duct stones and effectiveness of treatment.",[75,76,77],"Choledocholithiasis","Asymptomatic Condition","Quality of Life","2024-01-10",{"date":80,"type":30},"2024-01-22",{"date":82,"type":30},"2024-01-02",{"date":84,"type":19},"2028-12-31",{"name":36,"class":37},{"id":87,"slug":4,"hasResults":10,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":93,"targetDuration":94,"studyType":48,"phases":4,"briefSummary":95,"conditions":96,"keywords":98,"overallStatus":53,"whyStopped":4,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":62},"100223991","NCT02193464","Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk","Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea","EPICODE","Inclusion Criteria:\n\n* Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis\n* Followed up for at least 6 months for the correct diagnosis\n\nExclusion Criteria:\n\n* Patients who do not live in Daegu-Gyeongbuk province",{"count":47,"type":19},"10 Years","The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.",[97],"Idiopathic Chronic Inflammatory Bowel Disease",[99],"inflammatory bowel disease, registry, incidence, Korea","2021-01-08",{"date":102,"type":30},"2021-01-12",{"date":104,"type":30},"2014-09",{"date":106,"type":19},"2026-12",{"name":36,"class":37},""]